This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

EnteroMedics Inc (ETRM)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -26.13M -25.78M -23.46M -26.00M
Operating Gains/Losses 0.00 0.00 767.00 1.27K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 14.93K 26.63K -52.41K 0.00
(Increase) Decrease in Inventories 147.42K 143.27K -202.58K -1.07M
(Increase) Decrease In Other Current Assets 0.00 0.00 -813.06K 0.00
(Decrease) Increase In Payables 267.36K 60.73K -224.56K 367.49K
(Decrease) Increase In Other Current Liabilities -367.03K 515.45K -2.62M 3.87M
(Increase) Decrease In Other Working Capital -74.37K 246.76K 0.00 -176.99K
Other Non-Cash Items 6.32M 5.96M 4.23M 2.89M
Net Cash From Continuing Operations -19.38M -18.43M -22.48M -19.94M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -19.38M -18.43M -22.48M -19.94M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 1.00M 4.00M
Purchases of Property, Plant & Equipment -88.68K -416.01K -76.39K -252.27K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 -5.01M
Other Cash from Investing Activities 0.00 200.00K 0.00 6.33M
Cash Provided by Financing Activities
Net Cash From Investing Activities -88.68K -216.01K 923.61K 5.07M
Issuance of Debt 0.00 0.00 5.35M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 12.08M 24.08M 11.20M 14.65M
Repayment of Long-Term Debt -4.00M -3.00M -752.84K -922.00K
Repurchase of Capital Stock 0.00 0.00 -367.87K -1.21M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -284.70K -1.45M -50.00K 0.00
Net Cash From Financing Activities 7.79M 19.63M 15.38M 12.52M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -11.68M 988.70K -6.18M -2.35M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ETRM EnteroMedics Inc

Chart of ETRM

Analysts Ratings for ETRM

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ETRM Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs